HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models
- DOI
- 10.1158/1535-7163.mct-21-0320
- Published
- 2022-01-27
- Container
- Molecular Cancer Therapeutics
- Publisher
- American Association for Cancer Research (AACR)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1158/1535-7163.mct-21-0320,
title = {HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models},
author = {Valentí Gómez and Myria Galazi and Gregory Weitsman and James Monypenny and Fahad Al-Salemee and Paul R. Barber and Kenrick Ng and Richard Beatson and Bálint Szokol and László Orfi and Greg Mullen and Bart Vanhaesebroeck and Simon Chowdhury and Hing Y. Leung and Tony Ng},
year = {2022},
journal = {Molecular Cancer Therapeutics},
doi = {10.1158/1535-7163.mct-21-0320},
url = {https://doi.org/10.1158/1535-7163.mct-21-0320}
}RIS
TY - JOUR TI - HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models AU - Valentí Gómez AU - Myria Galazi AU - Gregory Weitsman AU - James Monypenny AU - Fahad Al-Salemee AU - Paul R. Barber AU - Kenrick Ng AU - Richard Beatson AU - Bálint Szokol AU - László Orfi AU - Greg Mullen AU - Bart Vanhaesebroeck AU - Simon Chowdhury AU - Hing Y. Leung AU - Tony Ng PY - 2022 JO - Molecular Cancer Therapeutics DO - 10.1158/1535-7163.mct-21-0320 UR - https://doi.org/10.1158/1535-7163.mct-21-0320 ER -
APA
Gómez, V., Galazi, M., Weitsman, G., Monypenny, J., Al-Salemee, F., Barber, P. R., Ng, K., Beatson, R., Szokol, B., Orfi, L., Mullen, G., Vanhaesebroeck, B., Chowdhury, S., Leung, H. Y., & Ng, T. (2022). HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models. Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.mct-21-0320
Source records
- crossref · retrieved 2026-09-27T12:09:37.874Z